Clinical Trial Update: Vortioxetine for Depressive Symptoms and Freezing of Gait in Parkinson Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating vortioxetine for depressive symptoms and freezing of gait in Parkinson disease is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder Unspecified
• Parkinson Disease

Drugs mentioned

• Vortioxetine (vortioxetine)

Snippet

Sponsor: Marianna Amboni | Conditions: Parkinson Disease, Idiopathic, Freezing of Gait | Phase 4 | Status: NOT_YET_RECRUITING